PER 4.48% 7.0¢ percheron therapeutics limited

FDA approves Sareptas Srp901 for the whole population, page-14

  1. 13,150 Posts.
    lightbulb Created with Sketch. 1380

    Here’s the thing
    FDA news today approving Sareptas SRP 901 is driving the share price up on PER

    why ?
    FDA has set a precedent
    Since we have done a combination study in Exon skipping drugs / we have placed ourselves as a combined useful therapy with Atl1102….
    Also Srp901 will still need Atl1102
    as a matter of fact the whole DMD market will need Atl1102

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.003(4.48%)
Mkt cap ! $57.69M
Open High Low Value Volume
6.5¢ 7.3¢ 6.3¢ $52.88K 793.8K

Buyers (Bids)

No. Vol. Price($)
3 171461 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 73444 3
View Market Depth
Last trade - 12.44pm 06/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.